ChromaDex (NASDAQ:CDXC) Issues Quarterly Earnings Results

ChromaDex (NASDAQ:CDXC – Get Free Report) released its earnings results on Thursday. The company reported $0.02 earnings per share for the quarter, Zacks reports. ChromaDex had a net margin of 1.62% and a return on equity of 5.06%. The firm had revenue of $25.58 million during the quarter, compared to the consensus estimate of $23.70 million. During the same period in the prior year, the firm earned ($0.01) EPS. ChromaDex updated its FY 2024 guidance to EPS.

Blue Owl Capital (NYSE:OWL) Issues Earnings Results, Meets Estimates

Blue Owl Capital (NYSE:OWL – Get Free Report) released its quarterly earnings results on Thursday. The company reported $0.20 earnings per share for the quarter, meeting the consensus estimate of $0.20, Zacks reports. The business had revenue of $600.88 million during the quarter, compared to analysts’ expectations of $565.93 million. Blue Owl Capital had a return on equity of 20.61% and a net margin of 4.95%. During the same quarter last year, the business posted $0.16 EPS.

Hims & Hers Health (NYSE:HIMS) Shares Down 5.4% Following Insider Selling

Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) shares traded down 5.4% during trading on Wednesday following insider selling activity. The stock traded as low as $19.80 and last traded at $21.04. 6,066,561 shares were traded during mid-day trading, a decline of 26% from the average session volume of 8,157,803 shares. The stock had previously closed at $22.24.

error: Content is protected !!